《2011NICE肺癌診治指南》內容簡(jiǎn)介：

    Since publication of NICE clinical guideline 24 in 2005, a number of newsystemic therapies have been granted a marketing authorisation by theEuropean Medicines Agency for use in people with NSCLC. NICE haspublished technology appraisals for pemetrexed, gefitinib and erlotinib. Othertechnology appraisals are in development.

    《2011NICE肺癌診治指南》內容預覽：

    This guidance updates and replaces NICE clinical guideline 24 （publishedFebruary 2005）。

    New and updated recommendations are included on communication,diagnosis and staging, selection of patients with non-small-cell lung cancer（NSCLC） for treatment with curative intent, surgery with curative intent forNSCLC, smoking cessation, combination treatment for NSCLC, treatment forsmall-cell lung cancer （SCLC）， managing endobronchial obstruction,managing brain metastases, and follow-up and patient perspectives.

    點(diǎn)擊下載***：《2011NICE肺癌診治指南》